Lineage, Inc.
LINE
Lineage, Inc.
Financials Mid Cap Updated Dec 26, 2025

Lineage pays you a 6.6% yield while earning just $0.45 a share next year.

If you own Lineage, you own a giant cold-storage landlord with thin profits and a fat payout.

$36.17
Market cap ~$8B · 52-week range $32–$62
55
Composite
Our overall rating — combines growth, value, risk, and momentum
55
/ 100

Below Average

Combines growth, value, risk, and momentum factors into a single institutional-grade score.

What it is
Lineage stores and moves frozen and refrigerated food through 488 temperature-controlled warehouses around the world.
How it gets paid
Last year Lineage made $5.3B in revenue. warehousing was the main engine at $3.71B, or 70% of sales.
What just happened
Lineage printed $0.03 EPS versus a -$0.10 estimate, but the bigger story was revenue that was basically flat.
B+ balance sheet — decent shape, but not bulletproof
6.6% dividend yield — cash in your pocket every quarter
0.5% return on capital — nothing to write home about
$0.45 fy2028 eps est
$6B fy2026 rev est
XVARY composite: 55/100 — below average
Lineage stores and moves frozen and refrigerated food through 488 temperature-controlled warehouses around the world.
Cold storage is not a spare-bedroom business. Lineage runs 488 warehouses with 86 million square feet and 3.1 billion cubic feet of capacity as of December 31, 2024. If your food supply chain depends on frozen space near ports, plants, and cities, you do not casually switch providers.
financials mid-cap reit cold-chain income
$5.3B annual revenue
warehousing
$3.71B
+3.0%
transportation services
$0.74B
+3.0%
value-added services
$0.42B
+2.0%
global integrated solutions
$0.32B
+4.0%
other
$0.11B
0.0%
Temperature-controlled warehousing
cold-storage facilities
$5.3B annual revenue
this is the whole business in the current public feed. You are not buying a collection of unrelated segments. You are buying one cold-chain property story at scale.
core revenue base
Revenue path
fy2026 outlook
$6B estimate
the next step up in revenue is visible. The catch is that more sales only matter if they lift returns above today's 0.5% return on capital.
scale test
Shareholder appeal
dividend case
6.6% yield
for now, the income stream does more work than the earnings line. That makes this look less like a growth story and more like a yield story with execution risk attached.
income hook
6.6%
dividend yield
Yield → cash payout on your purchase price → so what: you are being paid a lot up front because the market doubts the durability.
71.9%
insider ownership
Insider ownership → management's share count → so what: the people in charge feel the stock moves in their own net worth.
0.5%
return on capital
Return on capital → profit earned on invested money → so what: for every $100 tied up in the business, Lineage earns about $0.50.
488
warehouses
This is the physical network behind the story. Scale matters more when your product melts.
B+
Strength
  • balance sheet grade B+ — solid but not elite
  • risk rank 3 — safer than 50% of stocks
  • net profit margin 1.5% — keeps 2 cents of every dollar in revenue
  • return on equity 1% — $0.01 profit for every $1 investors have put in
B+ — functional but not a standout on the balance sheet.
source: institutional data · return history unavailable
beat estimates
Lineage printed $0.03 EPS versus a -$0.10 estimate, but the bigger story was revenue that was basically flat.
The latest reported quarter showed a profit against expectations, while company-reported Q4 2025 revenue was $1.336B, down 0.2% vs. prior year. Earlier interim results looked mixed too: September-quarter revenue rose 3% to $1.38B and adjusted EBITDA rose 2% to a record $341M, while adjusted FFO per share fell 6% to $0.85.
$1.34B
revenue
$0.03
eps
$341M
adjusted ebitda
the number that mattered
The number that mattered was $0.85 of adjusted FFO per share, down 6%, because REIT investors care less about accounting noise and more about cash available to support the dividend.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. Plain English, no spam.

Weekly updates Earnings alerts Plain English No spam

The main risk is simple: the dividend story is outrunning the profit story. On this page's numbers, Lineage looks more convincing as an income vehicle than as a high-return business.

Med
Dividend coverage pressure
A 6.6% yield gets attention. A 1.5% net margin does not leave much cushion underneath it. If operations wobble, the payout becomes the first thing investors debate.
income demand is supporting the equity case today. If that support weakens, the stock loses its cleanest selling point.
Med
Scale without returns
$5.3B in revenue is real scale. 0.5% return on capital and 1% return on equity are not the marks of a business compounding shareholder value at an attractive rate.
if revenue rises toward the $6B estimate without a better return profile, the stock stays stuck in income territory instead of rerating higher.
Med
The public data trail is still messy
This snapshot's risk and news feed includes items that look more like packaging and document references than clean operating catalysts. When the feed is noisy, investors can misread signal as story.
that does not change the business, but it does raise the odds of the stock swinging on half-formed narratives instead of clean fundamental read-throughs.
the combined picture is not hidden: high yield, thin profit, low returns, and a still-forming public narrative.
Source: institutional data · regulatory filings · risk analysis
Metric
Yield versus margin
6.6% dividend yield against a 1.5% net margin. Those two numbers belong in the same sentence every time you look at LINE.
Trend
Institutional buying streak
145 buyers versus 107 sellers in 3Q2025, with net buying across three straight quarters. Follow whether that support keeps showing up.
Calendar
The $6B revenue checkpoint
The next clean operating test is simple: can Lineage move from $5.3B in revenue toward the $6B fiscal 2026 estimate without the return profile staying stuck near 0.5%.
Risk
Target data that does not line up cleanly
The source feed shows a $27 midpoint while the 3–5 year range lists $40–$60. When target fields disagree, trust the operating numbers first.
risk profile
average
risk rank 3 — typical risk profile — neither especially safe nor risky.
Source: institutional data

institutions have been net buying for 3 consecutive quarters — 145 buyers vs. 107 sellers in 3q2025. total institutional holdings: 62.0M shares. net buying for 3 quarters.

Source: institutional data
3-5 year target range
$12 $41
$36 Current price
$27 Target midpoint · 25% from current · 3-5yr high: $60 (+65% · 18% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: DCF model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

See plans from $5/mo
LINE
XVARY Deep Dive
line
The full analysis is in the works.
What you'll get
DCF valuation model
Bull / base / bear scenarios
Competitive moat breakdown
Quarterly earnings tracker
Operating model projections
Risk matrix with kill criteria
Original price target + conviction
Updated with every earnings
Free · no spam · you'll be first to read it